CDEK by Data4ThePeople

Sign in Sign up

← All organizations

RadioMedix

For profitContributed to NMEWebsite ↗

Also known as: RADIOMEDIX | Radiomedix, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

First NDA

Last known activity

Dec 1, 2021

Timeline

2000s

Jun 1, 2006
RadioMedix— Founded

2020s

Sep 3, 2020
cu-64 dotatate— Marketing Organization
Sep 3, 2020
cu-64 dotatate— NDA Organization
Sep 3, 2020
cu-64 dotatate— NDA Secondary Org

Drugs by trial phase (5 distinct, 6 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (3 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

cu-64 dotatate

Recent trials (8)

NCT05153772Lead sponsorPhase 2Dec 1, 2021
NCT03673943Study directorPhase 3Aug 23, 2018
NCT03673943Lead sponsorPhase 3Aug 23, 2018
NCT03466216Lead sponsorPhase 1Feb 5, 2018
NCT02282137CollaboratorPhase 2Apr 1, 2015
NCT01879657CollaboratorPhase 1/Phase 2Mar 1, 2013
NCT01879657Overall official - principal investigatorPhase 1/Phase 2Mar 1, 2013
NCT00442533CollaboratorPhase 2/Phase 3Aug 1, 2005

Details

Founded: Houston, TX, US Jun 1, 2006
First NDA: Sep 3, 2020
Last known activity: Dec 1, 2021

Designations held

Orphan drug
Fast track
Priority review